| 000 | 01753 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517154209.0 | ||
| 264 | 0 | _c20180509 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2299-5684 | ||
| 024 | 7 |
_a10.1016/j.pharep.2017.02.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSultan, Faheem | |
| 245 | 0 | 0 |
_aShort-term exposure of erythropoietin impairs endothelial function through inhibition of nitric oxide production and eNOS mRNA expression in the rat pulmonary artery. _h[electronic resource] |
| 260 |
_bPharmacological reports : PR _cAug 2017 |
||
| 300 |
_a658-665 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDipeptides _xpharmacology |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xgenetics |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aSingh, Thakur Uttam | |
| 700 | 1 | _aKumar, Tarun | |
| 700 | 1 | _aRungsung, Soya | |
| 700 | 1 | _aRabha, Dipankar Jyoti | |
| 700 | 1 | _aVishwakarma, Anamika | |
| 700 | 1 | _aSukumaran, Susanth V | |
| 700 | 1 | _aKandasamy, Arunvikram | |
| 700 | 1 | _aParida, Subhashree | |
| 773 | 0 |
_tPharmacological reports : PR _gvol. 69 _gno. 4 _gp. 658-665 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharep.2017.02.003 _zAvailable from publisher's website |
| 999 |
_c27194379 _d27194379 |
||